RT Journal
A1 Gitelman SE, Haller MJ, Schatz D
T1 AUtologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus
JF JAMA
JO JAMA
YR 2009
FD August 12
VO 302
IS 6
SP 624
OP 625
DO 10.1001/jama.2009.1098
UL http://dx.doi.org/10.1001/jama.2009.1098
AB 
From the safety perspective, we also wondered whether any infectious issues aside from pneumonia were noted. In particular, we would like to know if primary infection of cytomegalovirus or Epstein-Barr virus or reactivation occurred. Epstein-Barr virus reactivation was noted in a trial of treating new onset type 1 diabetes with an anti-CD3 monoclonal antibody (ChAglyCD3).2